Marginally failed study for Europe [Study As­sess­ment]

posted by balakotu – India, 2018-04-24 09:30 (1868 d 05:14 ago) – Posting: # 18726
Views: 3,753

I have conducted a full replicate BE study for one of the highly variable product for Europe regulatory.
Based on the reference product variability, relaxed 90% Confidence Intervals is 75.18 to 133.01 for Cmax.
Study marginally failed with 90% upper CI data of 133.18
Is there any way to justify Europe regulatory authority(ies) to accept this study data? (DCP submission)


Edit: Category changed; see also this post #1 and #4. [Helmut]

Complete thread:

UA Flag
 Admin contact
22,616 posts in 4,740 threads, 1,614 registered users;
24 visitors (0 registered, 24 guests [including 6 identified bots]).
Forum time: 14:45 CEST (Europe/Vienna)

Mediocrity is a fungus of the mind.    Reif Larsen

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz